These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The rationale for using ursodeoxycholic acid in chronic liver disease.
    Author: Heller FR, Martinet JP, Henrion J, Schapira M, Gallez JF.
    Journal: Acta Gastroenterol Belg; 1990; 53(4):402-8. PubMed ID: 2096588.
    Abstract:
    The authors make a review of the literature and of their personal experience about the possible mechanisms of action and the beneficial therapeutic effects of ursodeoxycholic acid in primary biliary cirrhosis. They postulate that owing to its hydrophilic properties, ursodeoxycholic acid is more efficiently absorbed by the ileum than the other bile acids, so replacing the other bile acids in the bile acid pool, and that ursodeoxycholic acid is less toxic for hepatocytes than the other bile acids accumulating in the plasma and is also a choleretic.
    [Abstract] [Full Text] [Related] [New Search]